Aju IB Investment Co., Ltd. is a venture capital and private equity firm based in Seoul, South Korea. Established in 1974, it operates as a subsidiary of AJU Corporation Co., Ltd. The firm specializes in investing in small to medium-sized startups, focusing on sectors such as information technology, biotechnology, life sciences, and advanced materials. Aju IB Investment is particularly interested in high-technology ventures and companies involved in manufacturing. It provides not only capital but also consulting services that encompass business management, tax, accounting, legal matters, and technology support. The firm typically invests amounts ranging from $0.87 million to $2.61 million in venture capital and from $4.36 million to $17.45 million in private equity. Aju IB Investment also has a presence in Boston, Massachusetts, where it targets therapeutics and platform technologies with the potential for partnerships with Korean pharmaceutical companies. The firm primarily exits investments through initial public offerings and mergers and acquisitions.
Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medical information and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries. The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases. As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.
Selvatico
Seed Round in 2025
Selvatico is the first and largest domestic perfume firm to showcase a niche perfume collection that reinterprets French impressionist culture in a modern setting, as well as body and hand lotions.
Kovis Technology
Series B in 2024
Kovis Technology is a manufacturer of measurement and inspection equipment intended for global semiconductor and electronic industries.
PGT
Series D in 2024
PGT is a manufacturing company that develops specialty chemicals designed to be used as industrial raw materials.
SigzenGuru
Series A in 2024
SigzenGuru is an RF development company that specializes in frequency synthesizers, wideband converters, and communication system business.
Hurotics
Seed Round in 2024
Hurotics is a company with deep-tech technology related to human-robot fusion.Hurotix's wearable robots, notably the 'H-Flex', are modular and give personalized support based on the user's demands, assisting users in overcoming physical restrictions.
DEEPX
Funding Round in 2024
DEEPX is a South Korean company specializing in artificial intelligence solutions, focusing on both software and hardware systems. It develops advanced neural networks that enhance AI silicon for deep learning operations. By maximizing memory bandwidth, DEEPX's technology allows edge devices to operate efficiently, supporting the latest AI applications while promoting sustainable power usage. This approach enables businesses to implement energy-efficient on-device AI technology, streamlining their operations and improving performance.
KRISTIN
Series A in 2023
KRISTIN is a supplier of flat, sneakers, and boots.
Primemas
Seed Round in 2023
Primemas is a semiconductor startup headquartered in New York, with an R&D center located in Seoul. The company specializes in the development of low-cost, high-performance Hub Chiplet System-on-Chip (SoC) modules, known as Hublets, which are designed for the growing chiplet industry. These Hublets utilize high-bandwidth, low-latency device-to-device (D2D) interfaces, facilitating efficient infrastructure sharing with custom partner dies. This versatility makes them suitable for various markets, including CXL, artificial intelligence, cryptocurrency, and data analytics. By leveraging Primemas Hublets, clients can significantly reduce both the cost and time required to design and manufacture custom SoCs, achieving efficiencies that can be as much as tenfold.
True Balance
Debt Financing in 2023
True Balance is a digital wallet operated by Balancehero India Private Limited, providing a range of financial services aimed primarily at unbanked users in India. Launched in 2014 by CEO Charlie Lee, the platform has grown to serve 70 million users, offering facilities such as utility bill payments, online lending, e-commerce transactions, and essential insurance products. By focusing on accessibility and convenience, True Balance aims to meet the financial needs of individuals who may lack traditional banking services.
Enflow
Series A in 2023
Enflow develops solid-state batteries. The company develops next-generation secondary batteries to protect the future environment as environmental destruction resulting from fossil fuel consumption intensifies.
Returnit
Seed Round in 2023
RETURNIT is a service that replaces single-use containers with reusable containers used for food delivery.
COM2US ROCA
Seed Round in 2023
COM2US ROCA is a developer of a location-based social networking game that allow users to meet new people in neighborhood.
Live Anywhere
Series A in 2023
Live Anywhere is a leading short-term rental platform that provides customers with access to over 10,000 fully furnished homes across 165 cities worldwide. The company specializes in offering mid to long-term rental options, allowing individuals to secure accommodations for a month or longer. By facilitating direct reservations for shared living spaces, Live Anywhere aims to deliver convenient and affordable lodging solutions for those seeking extended stays.
Dreammark One
Venture Round in 2023
Dreammark One is a data center services company that provides cloud, infrastructure and security solutions.
BRLab
Venture Round in 2023
BRLab specializes in a sleep-sensing platform designed to enhance sleep quality through sophisticated analysis and improvement techniques. The company utilizes a patented sleep-enhancing technology that is scientifically validated, alongside an AI-powered algorithm known for its high reliability. This platform provides digital healthcare solutions focused on sleep technology, allowing users to monitor their sleep patterns and improve their sleep experiences without requiring significant lifestyle changes. Through its innovative approach, BRLab aims to facilitate better sleep for individuals by leveraging advanced technology and data-driven insights.
M3SEN
Series A in 2023
M3SEN is an artificial intelligence company specializing in advanced sensing and deep learning technologies aimed at enhancing productivity in the pig farming sector. The company focuses on 3D image reconstruction and lidar technology services, employing real-time monitoring of adult female pigs through sophisticated camera systems. By analyzing extensive data collected from these observations, M3SEN helps farmers address critical challenges such as complications during delivery, stillbirth, and suffocation related to fetal membranes. Through its innovative approach, M3SEN contributes to improving animal welfare and operational efficiency within the industry.
Wavebridge
Series B in 2022
Wavebridge is a prominent institutional digital asset company founded in November 2018, specializing in both traditional and cryptocurrency finance. The company offers a sophisticated digital asset management platform tailored for institutions and corporations, facilitating efficient trade execution and balance management. By connecting digital asset exchanges and blockchain wallets, Wavebridge addresses the challenges faced by organizations in executing large volume trades securely and optimally. Additionally, the platform provides reliable accounting and administrative services that adhere to legal and transparent procedures, ensuring a comprehensive suite of investment solutions enhanced by advanced data processing and artificial intelligence technology.
LBox
Series B in 2022
LBox is a developer of a legal technology platform designed to simplify the online search for legal information. The company's digital platform functions as a search engine, allowing legal professionals to easily access case law, legal documents, and scholarly articles. This tool enhances the research process by enabling users to study various legal surveys and publications relevant to their cases, ultimately streamlining the acquisition of crucial legal information.
DOWHAT
Seed Round in 2022
DOWHAT is a smart hotel integration platform.
Onconic Therapeutics
Series B in 2022
Onconic Therapeutics is dedicated to the research and development of innovative cancer treatments. The company focuses on creating next-generation anti-cancer therapies that target the mechanisms involved in cancer cell growth and DNA damage repair. By simultaneously suppressing key signal delivery agents and repair enzymes, Onconic aims to provide healthcare professionals with effective therapeutic options for treating various cancers.
JNPMEDI
Series A in 2022
JNPMEDI is focused on advancing the Korean medical infrastructure by developing a medical data platform that supports clinical research and trial operations. The company specializes in providing digital solutions that enhance the capabilities of regulatory authorities, pharmaceutical companies, and clinical research organizations. By offering clinical cloud alternatives, JNPMEDI enables healthcare professionals to effectively execute, manage, monitor, and audit clinical trials, thereby facilitating the progress of medical research and improving overall healthcare outcomes.
Laundrygo
Series C in 2022
Laundrygo is a on-demand laundry service.
GenKOre
Series A in 2022
GenKOre is a biotech company focused on developing innovative gene therapy solutions for medical emergencies. The company specializes in genetic scissors technology, which is integral to its healthcare platform. This platform not only provides gene therapy options but also includes educational programs that cover genome editing techniques, therapeutic approaches, and plant biotechnology. Through these offerings, GenKOre aims to enhance the genetic well-being of patients and the broader healthcare sector by providing valuable information and resources.
Boram
Seed Round in 2022
Boram is a provider of postnatal care services aimed at supporting mothers after childbirth. The company offers a range of specially designed services, including postnatal retreats and virtual postpartum coaching, to ensure that care is accessible to mothers. Boram's offerings encompass lactation and feeding assistance, as well as basic baby care, all focused on enhancing the health and well-being of both mothers and their babies. By catering to the needs of new mothers, Boram plays a crucial role in their postpartum experience.
ICT Compliance
Seed Round in 2022
ICT Compliance is a tech company specializing in authentication solutions.
Encell
Series C in 2022
ENCell is a biopharmaceutical company focused on developing and manufacturing innovative therapies. The company specializes in contract development and manufacturing services for biopharmaceuticals and is actively engaged in the development of cell and gene therapies targeting rare and incurable muscle diseases, including Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia. Through its commitment to advancing treatment options for these conditions, ENCell aims to address significant unmet medical needs in the field of muscle disorders.
Armored Fresh
Series A in 2022
Armored Fresh is a food company that specializes in producing plant-based cheese made from almond milk. Committed to sustainability, the company aims to create cheese alternatives that are beneficial for both people and animals. By leveraging advanced technology, Armored Fresh has developed a vegan cheese that closely mimics the taste and texture of traditional dairy cheese. The product line includes vegan cube cheese characterized by a soft texture and savory flavors, designed to enhance nutritional content and protein levels comparable to cow cheese. Through its offerings, Armored Fresh seeks to promote health and well-being while also protecting the environment.
MxT Biotech
Series A in 2022
MxT Biotech is a biotechnology company focused on developing innovative microfluidic platforms for cell engineering and immunotherapies. The company specializes in microfluid-based intracellular material delivery, offering gene-editing services and automated process equipment. Its cell therapy products include non-viral-based intracellular mass transfer platforms, which facilitate the delivery of genes and nucleic acids into cells. By generating flow in microtubules, MxT Biotech's technology creates temporary gaps in cell and nuclear membranes, allowing for efficient material transfer. This approach aims to enhance therapeutic outcomes in various applications, particularly in the fields of cell therapy and immunotherapy.
Wave
Seed Round in 2022
Wave is a food tech company that offers robot-based kitchen operation services for the food service industry.
Kimcaddie
Series A in 2022
Kimcaddie, a screen golf platform, which is providing End to End golf experience.
Live Anywhere
Seed Round in 2022
Live Anywhere is a leading short-term rental platform that provides customers with access to over 10,000 fully furnished homes across 165 cities worldwide. The company specializes in offering mid to long-term rental options, allowing individuals to secure accommodations for a month or longer. By facilitating direct reservations for shared living spaces, Live Anywhere aims to deliver convenient and affordable lodging solutions for those seeking extended stays.
Fine One
Seed Round in 2022
Fine One is a manufacturer specializing in OLED evaporator parts and vacuum components, catering to the display and semiconductor industries. The company focuses on developing essential components for semi core processes, specifically designed for 6th-generation mobile OLED evaporator materials. By providing advanced application parts, Fine One aims to support the growth of the downstream industry, enhancing technological capabilities in the manufacturing of OLED displays.
Daan Biotherapeutics
Seed Round in 2022
DAAN Biotherapeutics focuses on developing innovative cancer treatments, particularly for lung cancer. The company conducts research and development in immune-oncology, utilizing advanced strategies such as anticancer immune cell therapy that employs natural killer (NK) cells and T cell receptors. DAAN Biotherapeutics aims to create effective therapies by integrating various treatment modalities, including cell therapies, antibodies, and small molecule inhibitors. Their work involves conducting clinical trials based on independent research infrastructure, with the objective of providing healthcare providers with effective options for treating cancer patients.
bHaptics
Series B in 2022
bHaptics is a developer of advanced haptic devices that enhance the virtual reality experience by providing a sense of touch. The company offers a full-body haptic vest equipped with 40 feedback points, delivering precise and lag-free wireless interaction. This vest is designed to be compatible with various platforms, enabling users to experience haptic feedback while listening to music, watching movies, or playing games, even those without native support. Additionally, bHaptics produces wearable haptic gloves, further bridging the gap between the virtual world and the user's physical sensations. By integrating these technologies, bHaptics aims to create a more immersive and emotionally engaging experience for gamers and users alike.
Value Link Oil
Series A in 2022
Value Link Oil is a platform service company that provides transportation connection, data-based management, and consulting services.
KRISTIN
Seed Round in 2022
KRISTIN is a supplier of flat, sneakers, and boots.
iN Therapeutics
Series B in 2022
iN Therapeutics is a biotechnology company focused on developing innovative drug therapies for patients with incurable neurological diseases. The company is engaged in the creation of treatments targeting various conditions, including non-narcotic analgesics for Nav1.7, hearing loss, and other brain-related disorders. By advancing its drug development pipeline, iN Therapeutics aims to provide effective solutions for central nervous system diseases, ultimately enhancing the quality of life for affected individuals.
Organoid Sciences
Series B in 2022
Organoid Sciences is a drug development company based in Seongnam-si, South Korea, founded in 2018. The company specializes in organoid-based treatments and utilizes cannabinoid-based technology to create drugs aimed at addressing various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, contributing to advancements in healthcare solutions.
Willog Co., Ltd.
Series A in 2022
Willog is an IoT-based logistics intelligence company that provides real-time visibility across the entire supply chain through its proprietary sensor devices and platform. This enables businesses to monitor various data points such as location, temperature, humidity, and shock during transportation, helping them track assets and ensure consistent product quality. Willog’s solution helps identify potential issues in the logistics process in advance and suggests solutions to save time and reduce costs. It is applicable across various industries and empowers customers to make data-driven decisions. • Sensor Devices (Hardware) To meet the needs of various customers and transportation sectors, Willog offers a lineup of monitoring devices tailored to each logistics segment. These devices collect logistics data throughout the transport process and securely transmit it to the monitoring software. • Monitoring Solution (Software) Willog provides software optimized for logistics processes in tandem with its sensor devices. The software intuitively displays logistics condition data such as temperature, humidity, shock, and light levels collected during transport, eliminating the need for time-consuming manual tasks like post-delivery data mapping. Based on the collected data, the system analyzes shipment history to detect potential issues in advance during transportation and storage, helping to predict and minimize loss or cost. Additionally, Willog’s proprietary data analysis methodology, Willog Connected Intelligence, generates specialized analytics reports for each logistics domain—delivering insights beyond basic data logs and alerts.
JNPMEDI
Seed Round in 2022
JNPMEDI is focused on advancing the Korean medical infrastructure by developing a medical data platform that supports clinical research and trial operations. The company specializes in providing digital solutions that enhance the capabilities of regulatory authorities, pharmaceutical companies, and clinical research organizations. By offering clinical cloud alternatives, JNPMEDI enables healthcare professionals to effectively execute, manage, monitor, and audit clinical trials, thereby facilitating the progress of medical research and improving overall healthcare outcomes.
Victex
Venture Round in 2021
Victex is a manufacturer specializing in dry ice washing systems and operates its own dry ice production plant. The company is dedicated to supplying dry ice and has established a customer support center staffed with professional personnel to facilitate the immediate implementation of its systems across the country. This approach ensures that businesses have easy access to a reliable supply of dry ice, supported by localized parts and services. Victex aims to provide a stable supply chain to meet the needs of its customers efficiently.
Astron Security
Series A in 2021
Astron Security is a cloud security technology company that specializes in providing core technology services for businesses. It has developed a cloud workload security platform that focuses on detecting abnormalities and responding automatically to security threats. The platform offers automated asset management, real-time change monitoring, precise abnormality detection, and host health monitoring. Additionally, it optimizes firewall policy management through a three-step defense approach, allowing IT professionals to effectively manage firewall support in real-time across cloud workloads.
Kukka
Series B in 2021
Kukka, Inc. is a South Korean company that specializes in flower sales for various settings, including office spaces, showrooms, and events. Established in 2014 and based in Seoul, Kukka offers a range of services, such as flower subscription, bouquet delivery, same-day delivery, and custom floral design. The company aims to promote the enjoyment of flowers in everyday life, reflecting Finnish cultural values. In addition to individual customer services, Kukka also provides corporate flower solutions and floral decoration for events. Customers can conveniently order fresh flowers online, and the company further engages with its clientele through flower art classes and related accessories.
Onuii
Series A in 2021
Onuii is a mobile tutoring platform that provides personalized digital learning solutions for middle and high school students. The platform enables students to ask questions and receive answers from tutors online, facilitating effective study methods and preparation for entrance exams. Additionally, Onuii offers career counseling to help students navigate their educational and professional paths. By connecting students with private tutors, the platform not only addresses academic inquiries but also allows tutors to earn extra income through their expertise.
Dot Mill
Seed Round in 2021
Dot Mill is a mixed reality content production company.
Dabeeo
Series B in 2021
Dabeeo Inc., founded in 2012 and based in Seoul, South Korea, is an AI technology company that specializes in geospatial data. The company has developed a mapping technology platform that utilizes artificial intelligence and deep learning to manage and enhance spatial data. By digitizing the Earth's spatial information, Dabeeo creates a digital twin of the planet, providing businesses with essential digital spatial analysis data and insights. This innovative approach allows users to access live maps and locations, perform open-source map editing, and obtain high-quality map data, thereby improving productivity and convenience across various industries.
Dabeeo
Series B in 2021
Dabeeo Inc., founded in 2012 and based in Seoul, South Korea, is an AI technology company that specializes in geospatial data. The company has developed a mapping technology platform that utilizes artificial intelligence and deep learning to manage and enhance spatial data. By digitizing the Earth's spatial information, Dabeeo creates a digital twin of the planet, providing businesses with essential digital spatial analysis data and insights. This innovative approach allows users to access live maps and locations, perform open-source map editing, and obtain high-quality map data, thereby improving productivity and convenience across various industries.
Immunobiome
Series B in 2021
Immunobiome focuses on developing microbiome-targeted therapeutics aimed at treating challenging conditions such as cancer, autoimmune diseases, and neurological disorders. The company leverages advanced immunology, bioinformatics, and foundational microbiome research to create innovative healthcare solutions. Their platform addresses a range of health issues, including intractable immune disorders, allergies, organ transplant rejections, and diabetes-related inflammation. By targeting the microbiome, Immunobiome seeks to provide effective treatment options for patients suffering from these complex diseases.
LBox
Series A in 2021
LBox is a developer of a legal technology platform designed to simplify the online search for legal information. The company's digital platform functions as a search engine, allowing legal professionals to easily access case law, legal documents, and scholarly articles. This tool enhances the research process by enabling users to study various legal surveys and publications relevant to their cases, ultimately streamlining the acquisition of crucial legal information.
CORELINESOFT
Series C in 2021
CORELINESOFT develops medical software products.
SodaGift
Venture Round in 2021
SodaGift is an international gifting service that simplifies the process of sending gifts, particularly gift cards, across borders. The platform enables users to purchase and present gift cards from popular brands in the United States, South Korea, and Canada. By providing a seamless user experience and supporting multiple languages, SodaGift facilitates easy transactions and real-time transmission of gifts, allowing individuals living abroad to send thoughtful presents to their families back home.
AllRe
Seed Round in 2021
AllRe is a medical record data solution based on a hospital's electronic medical records (EMR). The software enables the precise inquiry and extraction of medical data, dataset creation, research, statistical analysis, and advanced visualization of medical data. The goal of the platform is enhance the quality and value of research through the utilization of patient data.
Willog Co.
Series A in 2021
Willog is an IoT-based logistics intelligence company that provides real-time visibility across the entire supply chain through its proprietary sensor devices and platform. This enables businesses to monitor various data points such as location, temperature, humidity, and shock during transportation, helping them track assets and ensure consistent product quality. Willog’s solution helps identify potential issues in the logistics process in advance and suggests solutions to save time and reduce costs. It is applicable across various industries and empowers customers to make data-driven decisions. • Sensor Devices (Hardware) To meet the needs of various customers and transportation sectors, Willog offers a lineup of monitoring devices tailored to each logistics segment. These devices collect logistics data throughout the transport process and securely transmit it to the monitoring software. • Monitoring Solution (Software) Willog provides software optimized for logistics processes in tandem with its sensor devices. The software intuitively displays logistics condition data such as temperature, humidity, shock, and light levels collected during transport, eliminating the need for time-consuming manual tasks like post-delivery data mapping. Based on the collected data, the system analyzes shipment history to detect potential issues in advance during transportation and storage, helping to predict and minimize loss or cost. Additionally, Willog’s proprietary data analysis methodology, Willog Connected Intelligence, generates specialized analytics reports for each logistics domain—delivering insights beyond basic data logs and alerts.
S-Alpha Therapeutics
Series A in 2021
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, founded in 2019. It focuses on researching and developing health applications and platform technologies designed to treat various diseases through digital devices. The company's product lineup includes SAT-001 for ophthalmology, SAT-002 for neurology, SAT-003 for oncology, and SAT-008 for addressing social issues. In addition to these applications, S-Alpha Therapeutics is engaged in developing therapeutic devices aimed at providing innovative treatment solutions for conditions that are challenging to address with existing medical technologies. The company strives to create a healthier and more equitable society by leveraging the intersection of biology and information technology to meet unmet medical needs.
Karis Bio
Series A in 2021
Karis Bio focuses on the development of innovative cell therapies aimed at treating cardiovascular diseases. The company utilizes patented technology that involves the generation of induced pluripotent stem cells (iPSCs) and their differentiation into endothelial cells. This approach is designed to provide effective treatments for patients suffering from cardiovascular conditions, enhancing their recovery and overall health.
PROTEINA
Series C in 2021
PROTEINA specializes in advanced technologies for protein interaction analysis and cancer diagnosis. Their SPID Platform allows for the precise detection and analysis of protein interactions at the single-molecule level, providing valuable insights into the molecular mechanisms behind biological processes. This innovative approach is particularly beneficial in fields such as drug discovery, diagnostics, and basic research. Additionally, PROTEINA has developed a technology aimed at cancer diagnosis that detects drug resistance signals by observing the real-time activation of cancer signal pathways through relevant proteins. This capability enables healthcare professionals to predict drug efficacy effectively, enhancing treatment strategies for cancer patients.
Wavebridge
Series A in 2021
Wavebridge is a prominent institutional digital asset company founded in November 2018, specializing in both traditional and cryptocurrency finance. The company offers a sophisticated digital asset management platform tailored for institutions and corporations, facilitating efficient trade execution and balance management. By connecting digital asset exchanges and blockchain wallets, Wavebridge addresses the challenges faced by organizations in executing large volume trades securely and optimally. Additionally, the platform provides reliable accounting and administrative services that adhere to legal and transparent procedures, ensuring a comprehensive suite of investment solutions enhanced by advanced data processing and artificial intelligence technology.
Reebonz Korea
Series A in 2021
Reebonz Korea operates as an online shopping site that offers various luxury brands' products and accessories.
PeopleBio
Post in 2021
PeopleBio develops diagnosis detection products and specializes in developing diagnostics for protein misfolding diseases.
Cookat
Series B in 2021
Cookat is a digital content creator focused on food and culinary trends, delivering engaging videos and recipes through various channels. The platform is optimized for mobile users, allowing it to effectively share food-related content on social media. Cookat aims to inspire and inform its audience about unique recipes and gourmet trends while facilitating the purchase of wholesale items, such as restaurant advertisements and home meal replacements, enabling consumers to connect and share with others. Through its innovative approach, Cookat endeavors to enhance the culinary experience for food enthusiasts.
GI Innovation
Series C in 2021
GI Innovation is a South Korean bio-venture company dedicated to the research and development of innovative biologics aimed at treating immuno-oncology and inflammation/immunology diseases. The company employs its proprietary GI-SMART platform technology, which optimizes the development of multi-targeting fusion protein therapeutics, ensuring high quality and productivity. Through its structured translational research approach, GI Innovation focuses on creating new protein-based drugs, particularly in the fields of immuno-oncology and allergy-related conditions, with the goal of improving patient outcomes worldwide.
Yipscell
Series A in 2021
Yipscell is a biotech company that develops IPSC stem cell therapy to diagnose and treat incurable diseases.
Mezoo
Series A in 2021
Mezoo is a medical device manufacturing company focused on developing biomedical sensor technology aimed at enhancing human health through accurate diagnoses. The company has created a compact, patch-type electrocardiogram that can be affixed to a patient’s chest. This device monitors heart activity in real-time, allowing physicians to effectively manage and prevent heart disease. By providing essential health data, Mezoo's technology supports healthcare professionals in delivering timely and informed medical care.
Gencurix
Venture Round in 2021
Gencurix Inc. is a South Korean company focused on developing molecular diagnostic products aimed at enhancing precision medicine. Established in 2011 and headquartered in Seoul, Gencurix offers a range of diagnostic kits, including the GenesWell BCT for breast cancer prognosis, the GenesWell ddEGFR Mutation Test for detecting mutations in non-small cell lung cancer, and the GenesWell CDx EGFR Mutation Test for companion diagnostics in lung cancer. These products are designed to support healthcare providers in making informed treatment decisions based on genetic information.
iN Therapeutics
Series A in 2021
iN Therapeutics is a biotechnology company focused on developing innovative drug therapies for patients with incurable neurological diseases. The company is engaged in the creation of treatments targeting various conditions, including non-narcotic analgesics for Nav1.7, hearing loss, and other brain-related disorders. By advancing its drug development pipeline, iN Therapeutics aims to provide effective solutions for central nervous system diseases, ultimately enhancing the quality of life for affected individuals.
People & Technology
Series A in 2021
People & Technology specializes in providing digital transformation-based artificial intelligence solutions focused on indoor geolocation and smart sensing. Their IndoorPlus+ platform, which includes Location Based Systems (LBS) and Real Time Location Systems (RTLS), serves various industries such as healthcare, manufacturing, defense, smart cities, and the public sector. The company has established a robust client base of over 100 corporate customers across sectors like banking, retail, energy, and public services, offering solutions that enhance employee safety, asset tracking, security and access control, and process efficiency. By implementing these industry-grade systems, clients have experienced increased productivity, improved operational processes, and mitigated corporate risks. Founded in 2013, People & Technology has emerged as a leading provider in South Korea and is actively expanding its presence in international markets.
Cenyx Biotech
Series A in 2021
Cenyx Biotech is focused on advancing healthcare through its innovative platform that utilizes diagnostic and therapeutic nano-compounds based on nanozymes and nanoparticles. The company is developing a unique nano-biotech agent designed to simultaneously eliminate superoxide, hydrogen peroxide, and hydroxyl radicals. This approach aims to help patients and healthcare practitioners manage excessive inflammatory reactions, particularly in the early stages of subarachnoid hemorrhage. By addressing these critical factors, Cenyx Biotech seeks to transform treatment options and improve patient outcomes in the healthcare sector.
VEStellaLab
Series A in 2021
VEStellaLab specializes in AI-based navigation services aimed at improving parking experiences for both drivers and autonomous vehicles. Its flagship solution, WatchMile, addresses conventional navigation limitations by providing real-time parking availability and guiding users to optimal parking locations. The technology employs advanced methods such as converting CAD files into lighter digital maps, vision AI recognition, and precise positioning algorithms. This indoor navigation system not only simplifies parking but also alleviates congestion in parking facilities. In addition to WatchMile, VEStellaLab offers Zerocruising, a service tailored for autonomous vehicles, which leverages indoor positioning and vision-AI technologies to enhance parking efficiency. Through these innovative services, VEStellaLab creates significant value in urban transportation and smart city infrastructures.
Biobab AiBIO
Series A in 2021
Biobab AiBIO is a biotechnology company focused on drug development through the integration of artificial intelligence. It specializes in creating innovative technologies for efficient drug discovery, particularly aimed at addressing intractable and rare diseases. The company has developed bio-space voyager technology that enhances the capabilities of traditional X-ray crystallography by employing cryogenic electron microscopy (cryo-EM). This advanced approach allows for the detailed analysis of the three-dimensional structure of new target proteins, facilitating the identification and development of novel drugs for unique therapeutic targets.
MBD
Series B in 2021
MBD is a biotechnology company that specializes in 3D cell culture platforms.
AbTis
Series B in 2021
AbTis is a biotechnology company specializing in antibody-drug conjugation technology and drug solubilization. Its innovative approach aims to enhance the safety and efficacy of existing antibody-drug conjugates without the need for modifications to the antibodies themselves. This technology is applicable to native antibodies, commercial antibodies, and novel antibodies that are still under development. By providing a means for medical professionals to access effective antibody-drug conjugates, AbTis contributes to advancements in targeted therapies in the medical field.
S-Alpha Therapeutics
Seed Round in 2020
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, founded in 2019. It focuses on researching and developing health applications and platform technologies designed to treat various diseases through digital devices. The company's product lineup includes SAT-001 for ophthalmology, SAT-002 for neurology, SAT-003 for oncology, and SAT-008 for addressing social issues. In addition to these applications, S-Alpha Therapeutics is engaged in developing therapeutic devices aimed at providing innovative treatment solutions for conditions that are challenging to address with existing medical technologies. The company strives to create a healthier and more equitable society by leveraging the intersection of biology and information technology to meet unmet medical needs.
LBox
Seed Round in 2020
LBox is a developer of a legal technology platform designed to simplify the online search for legal information. The company's digital platform functions as a search engine, allowing legal professionals to easily access case law, legal documents, and scholarly articles. This tool enhances the research process by enabling users to study various legal surveys and publications relevant to their cases, ultimately streamlining the acquisition of crucial legal information.
CORELINESOFT
Series B in 2020
CORELINESOFT develops medical software products.
5minlab
Series A in 2020
5minlab is a game development company located in Seoul, South Korea, specializing in PC and mobile games, as well as virtual reality titles. Founded in 2013, the company has released five PC and mobile games, three VR games, and 24 hyper-casual games, showcasing its diverse portfolio and expertise in various genres, including multiplayer, strategy, and puzzles. Since 2018, 5minlab has been developing the PvP game "Smash Legends," which gained substantial global attention and led to a successful Series A investment in 2020. The company employs a team of 70 professionals with backgrounds in notable projects, enhancing its creative and technical capabilities. With plans to release a new game in 2024, 5minlab aims to establish itself as a developer capable of creating globally recognized intellectual properties.
Autotelic Bio
Series A in 2020
Autotelic Bio is a biotechnology company dedicated to researching and developing innovative anti-cancer drugs. The company aims to enhance the efficacy and reduce the side effects of existing oncology treatments by focusing on precise targeting and optimization of therapies. In addition to its primary focus on cancer, Autotelic Bio seeks to expand its research efforts into immuno-oncology drugs that may also address conditions such as diabetes, hypertension, and diseases affecting the central nervous system. Through its specialized approach, Autotelic Bio is committed to improving treatment options for patients facing various health challenges.
Laundrygo
Series B in 2020
Laundrygo is a on-demand laundry service.
Kukka
Series A in 2020
Kukka, Inc. is a South Korean company that specializes in flower sales for various settings, including office spaces, showrooms, and events. Established in 2014 and based in Seoul, Kukka offers a range of services, such as flower subscription, bouquet delivery, same-day delivery, and custom floral design. The company aims to promote the enjoyment of flowers in everyday life, reflecting Finnish cultural values. In addition to individual customer services, Kukka also provides corporate flower solutions and floral decoration for events. Customers can conveniently order fresh flowers online, and the company further engages with its clientele through flower art classes and related accessories.
Organoid Sciences
Series A in 2020
Organoid Sciences is a drug development company based in Seongnam-si, South Korea, founded in 2018. The company specializes in organoid-based treatments and utilizes cannabinoid-based technology to create drugs aimed at addressing various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, contributing to advancements in healthcare solutions.
Macaron M
Series A in 2020
Macaron M is a mobile application that specializes in providing ride-hailing services. The platform allows users to schedule car reservations and choose from a variety of vehicles, all while facilitating a simplified payment process. By offering features such as discounts and the ability to make reservations via phone, Macaron M aims to enhance the travel experience for its customers.
Seer
Series D in 2019
Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.
Sparkplus
Series B in 2019
Sparkplus, founded in 2016 and based in Seoul, South Korea, specializes in providing comprehensive solutions for office environments. The company designs and manages real estate contracts, interior design, construction, and furniture arrangements specifically for coworking spaces. By addressing various challenges faced by businesses regarding their office needs, Sparkplus aims to streamline the process, enabling clients to focus on their core activities without the distraction of managing their office setup.
Adapt
Series A in 2019
Adapt is a brand and content marketing platform that focuses on D2C concept, customer feedback and constant analysis.
FamePick
Series A in 2019
FamePick Inc. is a subscription-based platform established in 2016 and located in Sunnyvale, California, that serves the advertising and marketing industry. It specializes in facilitating celebrity-driven marketing campaigns on social media, enabling businesses to effectively connect with audiences. The platform offers seasoned creators and influencers a suite of tools designed to help them manage their personal brands while maintaining their narrative and integrity. These tools assist users in identifying like-minded partners, strengthening relationships, and diversifying their presence across various platforms and media. Additionally, FamePick provides a custom automated media kit that includes audience reach, demographics, rates, and recent brand collaborations, empowering creators to enhance their market value and grow their businesses.
Leferi
Series B in 2019
Leferi is a beauty influencer business group that fosters influencers, marketing, and commerce.
Fresh Easy
Series C in 2019
Fresh Easy is a distributor of meal kits.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.